Leen Kawas, Biotech Executive

Leen Kawas is a biotech executive who has made significant contributions to the field of biotechnology and has emerged as a leader in the industry. With her expertise in neuroscience, she has been instrumental in developing innovative treatments for neurological disorders.

Leen Kawas obtained her undergraduate degree from the University of Jordan and later completed her Ph.D. in molecular and cellular biology at the University of Kansas. She then worked as a postdoctoral fellow at the University of California, Irvine, focusing on neurodegenerative diseases’ molecular mechanisms.

In 2015, Kawas co-founded M3 Biotechnology, a biotech company that focuses on developing treatments for neurological disorders such as Alzheimer’s and Parkinson’s disease. As the CEO of M3 Biotechnology, Kawas has played a key role in the company’s growth and success. She has raised millions of dollars in funding and has led the development of the company’s lead drug candidate, a treatment for Alzheimer’s disease.

Under Kawas’s leadership, M3 Biotechnology has received numerous accolades, including being named one of the “Top 10 Innovators in Biotech” by Scientific American Worldview and being selected as a finalist for the Washington Biotechnology & Biomedical Association’s Life Science Innovation Northwest conference.

Leen Kawas is also an active member of the biotech community. She serves on the board of directors for the Biotechnology Innovation Organization (BIO), a leading industry organization representing over 1,000 biotech companies, academic institutions, and state biotech centers.

Several industry organizations have recognized Kawas’s achievements. In 2018, she was named one of the “Top 100 Most Influential People in the World of Drug Development” by The Medicine Maker magazine. She was also named one of the “100 Most Inspiring Leaders in the Life Sciences Industry” by PharmaVOICE magazine in 2019.

Leen Kawas is passionate about advancing treatments for neurological disorders and improving patient outcomes. Her dedication to biotechnology and her contributions to the industry have positioned her as a leader and role model for women in STEM fields.